From: Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trial
Renal function
Dose of ZA (mg)
eGFR ≥ 60 mL/min
4.0
eGFR 50–59 mL/min
3.5
eGFR 40–49 mL/min
3.3
eGFR 30–39 mL/min
3.0
eGFR < 30 mL/min
0.0